Synthesizing the insights from immune infiltration metrics, single-cell transcriptomics, and M2 marker co-expression analyses, we postulate that SLC3A2 catalyzes a transformative effect on the glioma tumor microenvironment, particularly by steering macrophage polarization towards an M2 phenotype. Here, SLC3A2 is linked to central nervous system cancer.